Company / Operating Cash Flow per Share
Insight Molecular Diagnostics Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.19
FY2025
5-year range
-$7.68 / -$0.38
FY2021-FY2025
Trend
+58.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-7.68 to $-1.19 over the past 2 years.
Based on SEC 10-K filings.
-1.19 in FY2025.
Improved from $-7.68 to $-1.19 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 58.0% year-over-year.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.19 | +58.0% |
| FY2024 | -$2.82 | +63.2% |
| FY2023 | -$7.68 | -1871.2% |
| FY2022 | -$0.39 | -3.7% |
| FY2021 | -$0.38 | -8.7% |
| FY2020 | -$0.35 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026